PHARMACOKINETICS OF CIS-DICHLORO-TRANS-DIHYDROXY-BIS-ISOPROPYLAMINE PLATINUM-IV (CHIP) IN PATIENTS WITH ADVANCED CANCER

被引：1
作者：
PENDYALA, L
GRECO, W
COWENS, JW
MADAJEWICZ, S
CREAVEN, PJ
机构：
[1] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,CTR COMP,BUFFALO,NY 14263
[2] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT EXPTL THERAPEUT,BUFFALO,NY 14263
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1983年 / 11卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：23 / 28
页数：6
相关论文
共 28 条
  • [21] A COMPARATIVE-STUDY OF THE DISTRIBUTION IN THE MALE-RAT OF PLATINUM-LABELED CIS-DICHLORODIAMMINE PLATINUM(II), CIS-TRANS-DICHLORODIHYDROXY-BIS-(ISOPROPYLAMINE) PLATINUM(I), AND CIS-DICHLORO-BIS-CYCLOPROPYLAMINE PLATINUM(II)
    HARRISON, R
    MCAULIFFE, CA
    ZAKI, A
    BAER, J
    SHARMA, H
    SMITH, A
    JACKSON, H
    FOX, BW
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1983, 10 (02) : 90 - 95
  • [22] INVIVO DISTRIBUTION STUDIES OF RADIOACTIVELY LABELED PLATINUM COMPLEXES - CIS-DICHLORODIAMMINE PLATINUM(II), CIS-TRANS-DICHLORODIHYDROXY-BIS-(ISOPROPYLAMINE) PLATINUM(IV), CIS-DICHLORO-BIS-CYCLOPROPYLAMINE PLATINUM(II), AND CIS-DIAMMINE 1,1-CYCLOBUTANEDICARBOXYLATE PLATINUM(II) IN PATIENTS WITH MALIGNANT DISEASE, USING A GAMMA-CAMERAU
    OWENS, SE
    THATCHER, N
    SHARMA, H
    ADAM, N
    HARRISON, R
    SMITH, A
    ZAKI, A
    BAER, JC
    MCAULIFFE, CA
    CROWTHER, D
    FOX, BW
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 14 (03) : 253 - 257
  • [23] CHARACTERIZATION OF INVITRO DEOXYRIBONUCLEIC-ACID BREAKAGE AND CROSS-LINKING INDUCED BY BIS(ISOPROPYLAMINE)-TRANS-DIHYDROXY-CIS-DICHLOROPLATINUM(IV)
    MONG, S
    EUBANKS, DC
    PRESTAYKO, AW
    CROOKE, ST
    BIOCHEMISTRY, 1982, 21 (13) : 3174 - 3180
  • [24] THE EFFECTS OF DICHLORO-TRANS-DIHYDROXY-BIS-ISOPROPYL-AMINE-PLATINUM-IV ON THE PRIMARY CELL-MEDIATED CYTO-TOXIC RESPONSE
    SCHLAEFLI, E
    EHRKE, MJ
    MIHICH, E
    IMMUNOPHARMACOLOGY, 1983, 6 (02): : 107 - 122
  • [25] MECHANISM OF ACTION OF CIS-DICHLORO-BIS (ISOPROPYLAMINE) TRANS DIHYDROXYPLATINUM IV (CHIP) ON CHINESE-HAMSTER AND C3H MOUSE-TUMOR CELLS AND ITS INTERACTION WITH X-IRRADIATION
    NIAS, AHW
    BOCIAN, E
    LAVERICK, M
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1979, 5 (08): : 1341 - 1344
  • [26] PHARMACOKINETICS OF LIPOSOME-ENTRAPPED CIS-BIS-NEODECANOATO-TRANS-R,R-1,2-DIAMINOCYCLOHEXANE PLATINUM(II) AND CISPLATIN GIVEN IV AND IP IN THE RAT
    VADIEI, K
    SIDDIK, ZH
    KHOKHAR, AR
    ALBAKER, S
    SAMPEDRO, F
    PEREZSOLER, R
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 30 (05) : 365 - 369
  • [27] Platinum(IV) cisplatin derivative trans, cis, cis-bis(heptanoato)amine(cyclohexylamine)dichloridoplatinum(IV) has an enhanced therapeutic index compared to cisplatin for the treatment of non-small cell lung cancer
    Shi, Yi
    Koneru, Bhuvaneswari
    Redfearn, Warren
    Miller, Michael L.
    Myers, Lara
    Di Pasqua, Anthony J.
    INORGANICA CHIMICA ACTA, 2014, 423 : 215 - 219
  • [28] trans,cis,cis-Bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a Prodrug Candidate for the Treatment of Oxaliplatin-Refractory Colorectal Cancer
    Gandin, Valentina
    Marzano, Cristina
    Pelosi, Giorgio
    Ravera, Mauro
    Gabano, Elisabetta
    Osella, Domenico
    CHEMMEDCHEM, 2014, 9 (06) : 1299 - 1305
123